Precigen (PGEN) Cash & Equivalents (2012 - 2026)
Precigen's Cash & Equivalents came in at $16.33 million for Q2 2026, up 18.7% from $13.76 million a year earlier and up 118.3% from the prior quarter.
Powered by 
Analysis
Precigen (PGEN) Cash & Equivalents (2012 - 2026) Analysis & Trends
At the end of FY2025, Precigen's Cash & Equivalents was $30.23 million, up 2.4% from FY2024.
- Cash & Equivalents has increased in each of the last three years, though with a five-year compound annual growth rate of -10.2% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $29.52 million in FY2024 (+289.5%), $7.58 million in FY2023 (+56.0%), $4.86 million in FY2022 (-86.7%) and $36.42 million in FY2021 (-29.7%).
- The five-year range for quarterly Cash & Equivalents is $4.86 million (Q4 2022) to $43.84 million (Q2 2022).
- Year-over-year, Cash & Equivalents has increased for three consecutive quarters, with growth averaging 52.4% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q4 2024 (growth of 289.5%), and the weakest in Q4 2022 (a decline of 86.7%).
- Business Quant data shows PGEN's Cash & Equivalents at $7.48 million (Q1 2026), $30.23 million (Q4 2025) and $14.32 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Precigen | 3.06 Bn | 3.06 Bn | 52.17 Mn | 16.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.33 Mn |
| Mar 31, 2026 | 7.48 Mn |
| Dec 31, 2025 | 30.23 Mn |
| Sep 30, 2025 | 14.32 Mn |
| Jun 30, 2025 | 13.76 Mn |
| Mar 31, 2025 | 6.06 Mn |
| Dec 31, 2024 | 29.52 Mn |
| Sep 30, 2024 | 24.73 Mn |
| Jun 30, 2024 | 9.35 Mn |
| Mar 31, 2024 | 17.48 Mn |
| Dec 31, 2023 | 7.58 Mn |
| Sep 30, 2023 | 10.08 Mn |
| Jun 30, 2023 | 16.55 Mn |
| Mar 31, 2023 | 9.74 Mn |
| Dec 31, 2022 | 4.86 Mn |
| Sep 30, 2022 | 9.07 Mn |
| Jun 30, 2022 | 43.84 Mn |
| Mar 31, 2022 | 40.32 Mn |
| Dec 31, 2021 | 36.42 Mn |
| Sep 30, 2021 | 41.73 Mn |
API Access
Precigen Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PGEN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PGEN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PGEN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();